Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma
- Juliet E. Wolford
- , Jiaru Bai
- , Kathleen N. Moore
- , Rebecca Kristeleit
- , Bradley J. Monk
- , Krishnansu S. Tewari
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations